STIMULAN RAPID CURE
Report
- Report Number
- 9617083-2014-00010
- Event Type
- Malfunction
- Date Received
- April 9, 2014
- Date of Event
- March 11, 2014
- Report Date
- March 11, 2014
- Manufacturer
- BIOCOMPOSITES LTD.
- Product Code
- MQV
- PMA / PMN Number
- K021551
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- OTHER
Narratives
COMORBIDITIES DETAILS PROVIDED: AGE, PREVIOUS LEFT KNEE INFECTION WITH STAPH AUREUS, CURRENT LEFT KNEE INFECTION WITH (B)(6), HTN, CAD, ANEMIA. SURGERY DETAILS: 1.2 POWDERED TOBRAMYCIN AND 1G VANCOMYCIN HAD BEEN USED PER 10CC STIMULAN RAPID CURE - 50CC WAS USED. 'VANCOMYCIN BEADS' PLACED PERIOPERATIVELY, THE PATIENT WAS PLACED ON VANCOMYCIN IV POST OP, AND DEVELOPED VANCO TOXICITY ON POD3 WITH ASSOCIATED RENAL FAILURE, AND HYPERCALCEMIA ON POD3 ALSO. CALCIUM LEVELS AS HIGH AS 15.3 POD27 (DESPITE HEMODIALYSIS) THEN STARTED TO DROP, NORMAL LEVELS ON POD30. STATUS AS AT (B)(6) 2014: PATIENT IS DOING WELL, THOUGH WEAK PHYSICALLY, ON SUPPLEMENTAL02, WILL NEED PHYSICAL REHABILITATION, ELECTROLYTES ARE NORMAL, OFF IV THERAPY, OFF HEMODIALYSIS, WILL BE PLACED ON ORAL ANTIBIOTICS UPON D/C TO REHAB. SUSPECTED ROOT CAUSE: A LARGE AMOUNT OF ANTIBIOTICS HAVE BEEN USED, LOCALLY AND IV - VANCOMYCIN TOXICITY HAD DEVELOPED AND ASSOCIATED RENAL FAILURE, WHICH MAY HAVE CONTRIBUTED TO HYPERCALCEMIA. HYPERCALCEMIA AND RENAL COMPROMISED PATIENTS ARE CONTRAINDICATED. ADDITIONAL LOT#: 09/13R194. ADDITIONAL DEVICE MANUFACTURE DATE: 09/01/2013.
THE CUSTOMER REPORTED THAT A PROCEDURE UNDERTAKEN ON 18/02/2014 WAS I AND D WITH POLY EXCHANGE FOR EARLY INFECTION IN A MULTIPLY OPERATED PATIENT WITH A DISTAL FEMORAL REPLACEMENT. APPROXIMATELY 3 WEEKS AFTER RECEIVING 50 CC STIMULAN RAPID CURE, THE PATIENT HAD UNEXPLAINED HYPERCALCEMIA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 212940 | STIMULAN RAPID CURE | BONE VOID FILLER/GRAFT EXTENDER | MQV | BIOCOMPOSITES LTD. | 08/13R192 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization |